Serum tumor marker in rodent prostate cancer models
AssigneeLondon Health Sciences Centre Research Inc.
InventorsJim W. Xuan, Joseph L. Chin
Life of this patent
Estimating the term…
Abstract
The present invention relates to a rodent serum marker for prostate cancer comprising b-microseminoprotein (PSP94) and diagnostic methods thereof. The present invention also relates to a recombinant sequence to raise a ligand of a specific binding affinity to a rodent serum marker for prostate cancer, which comprises the following amino acid sequence: (SEQ ID NO: 1) MGGSHHHHHHGMASMTGGGGMGRNTRYDDDDKDRWGSWVCSIENREIFPN QMSDDCMDADGNKHFLNTPKKNCTWCSCDKTSITCCTNATPLSYDKDNCD VQFHPENCTYSVVDRKNPGKTCRVDSWTM.
Claims1
A recombinant rodent serum marker for prostate cancer, which comprises the following amino acid sequence:
- (SEQ ID NO:
- 1)
- MGGSHHHHHHGMASMTGGGGMGRNTRYDDDDKDRWGSWVCSIENREIFPN
- QMSDDCMDADGNKHFLNTPKKNCTWCSCDKTSITCCTNATPLSYDKDNCD
- NQFHPENCTYSVVDRKNPGKTCRVDSWTM.
Dependencies are inferred from the claim text.